Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Bausch Health Companies Inc |
20/12 | 7,470 USD
+1,08% |
+1,08% |
|
Baxter |
20/12 | 29,500 USD
+2,08% |
+2,08% |
Bayer AG |
20/12 | 18,936 EUR
+0,35% |
+0,35% |
|
Beam Therapeutics Inc |
20/12 | 29,010 USD
+8,04% |
+8,04% |
|
Becton, Dickinson And Co. |
20/12 | 227,680 USD
+1,72% |
+1,72% |
|
BeiGene Ltd |
20/12 | 176,500 USD
+1,02% |
+1,02% |
|
Bellerophon Therapeutics Inc |
18/12 | 0,012 USD
-25,47% |
-25,47% |
|
Bellring Brands Inc |
20/12 | 76,100 USD
-2,20% |
-2,20% |
Benchmark Holdings plc |
18/12 | 32,550 GBX
+1,09% |
+1,09% |
|
Benitec Biopharma Inc |
20/12 | 11,410 USD
-6,24% |
-6,24% |
|
Beximco Pharmaceuticals Limited - GDR - Reg S |
20/12 | 36,500 GBX
0,00% |
0,00% |
|
BeyondSpring Inc |
20/12 | 1,590 USD
+2,58% |
+2,58% |
|
Bicycle Therapeutics Plc |
20/12 | 14,680 USD
-2,13% |
-2,13% |
|
Bio-Path Holdings Inc |
20/12 | 1,260 USD
-15,44% |
-15,44% |
|
Bio-Rad Laboratories Inc. |
18/12 | 325,850 USD
-3,33% |
-3,33% |
|
Bio-Rad Laboratories Inc. |
20/12 | 327,470 USD
+0,47% |
+0,47% |
|
Bio-Techne Corp |
20/12 | 73,170 USD
+2,49% |
+2,49% |
|
BioCardia Inc. |
20/12 | 1,970 USD
+7,07% |
+7,07% |
|
Biocryst Pharmaceuticals Inc. |
20/12 | 7,570 USD
+2,44% |
+2,44% |
|
Biogen |
20/12 | 146,470 USD
-0,62% |
-0,62% |
|
Biohaven Ltd |
20/12 | 36,260 USD
+2,60% |
+2,60% |
|
Biolife Solutions Inc |
20/12 | 27,390 USD
+4,90% |
+4,90% |
|
Bioline Rx Ltd |
20/12 | 0,203 USD
+0,50% |
+0,50% |
|
Biomarin Pharmaceutical Inc. |
20/12 | 65,660 USD
+1,02% |
+1,02% |
|
Biomerica Inc. |
20/12 | 0,279 USD
+4,85% |
+4,85% |
Biomerieux |
19/12 | 101,300 EUR
-0,78% |
-0,78% |
|
BiomX Inc |
20/12 | 0,620 USD
+8,89% |
+8,89% |
|
Bionano Genomics Inc |
20/12 | 0,195 USD
-2,74% |
-2,74% |
|
BioNTech SE |
20/12 | 113,080 USD
+1,56% |
+1,56% |
|
Biophytis |
20/12 | 0,340 EUR
+1,19% |
+1,19% |
|
BioRestorative Therapies Inc |
20/12 | 1,550 USD
+6,90% |
+6,90% |
BioSenic |
20/12 | 0,006 EUR
+3,28% |
+3,28% |
|
Biosig Technologies Inc |
20/12 | 1,340 USD
+3,08% |
+3,08% |
Biosyent Inc |
20/12 | 11,740 CAD
+0,86% |
+0,86% |
|
Biosynex |
20/12 | 1,296 EUR
-4,00% |
-4,00% |
|
Biotest AG |
20/12 | 41,400 EUR
0,00% |
0,00% |
|
Biotest AG |
20/12 | 25,800 EUR
-1,53% |
-1,53% |
|
BioVie Inc |
20/12 | 1,900 USD
-8,65% |
-8,65% |
|
BioXcel Therapeutics Inc |
20/12 | 0,341 USD
+8,12% |
+8,12% |
|
Black Diamond Therapeutics Inc |
20/12 | 2,220 USD
+1,37% |
+1,37% |
|
Bluebird bio Inc |
20/12 | 8,500 USD
-7,91% |
-7,91% |
|
Bluelinea SA |
20/12 | 0,810 EUR
-4,71% |
-4,71% |
|
Blueprint Medicines Corp |
20/12 | 90,140 USD
+1,36% |
+1,36% |
|
Boiron |
19/12 | 26,850 EUR
-0,56% |
-0,56% |
|
Bone Biologics Corp |
20/12 | 1,010 USD
-3,81% |
-3,81% |
|
Boston Scientific Corp. |
20/12 | 88,950 USD
+0,33% |
+0,33% |
|
Boundless Bio Inc. |
20/12 | 2,590 USD
+2,78% |
+2,78% |
|
BRAIN Biotech AG |
20/12 | 3,470 EUR
-1,70% |
-1,70% |
|
Brainstorm Cell Therapeutics, Inc. |
20/12 | 2,280 USD
+9,62% |
+9,62% |
|
Brainsway Ltd |
20/12 | 9,240 USD
+3,12% |
+3,12% |
|
BriaCell Therapeutics Corp |
20/12 | 0,561 USD
-4,12% |
-4,12% |
|
BridgeBio Pharma Inc |
20/12 | 26,490 USD
+1,07% |
+1,07% |
|
Bristol-Myers Squibb Co. |
20/12 | 57,330 USD
+1,83% |
+1,83% |
|
Bruker Corp |
20/12 | 57,000 USD
+3,09% |
+3,09% |